Health economic effect of leuprorelin acetate depot injection for 6 months (brand) for prostate cancer patients compared to that for 3 months (generic).

Health economic effect of leuprorelin acetate depot injection for 6 months (brand) for prostate cancer patients compared to that for 3 months (generic). - Health economic effect of leuprorelin acetate depot injection for prostate cancer patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024759

Enrollment

100

Registered

2016-11-08

Start date

2016-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: prostate cancer patients

Exclusion criteria

Exclusion criteria: patients who cannot answer a questionnaire survey

Design outcomes

Primary

Measure	Time frame
Monetary value of reduced injection frequency	—

Countries

Japan

Contacts

Public ContactTomomi Takeshima

Millian Japan Healthcare Practice and Data Analysis

tomomi.takeshima@milliman.inc03-5211-7031

Outcome results